A short time window to profit from protection of blood-induced cartilage damage by IL-4 plus IL-10

Rheumatology (United Kingdom)

Volumn 52, Issue 9, 2013, Pages 1563-1571

  van Meegeren, Monique E R ^a,b   Roosendaal, Goris ^b   van veghel, Karin ^a   Mastbergen, Simon C ^a   Lafeber, Floris P J G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Aspiration; Haemarthrosis; Haemophilia; IL 10; IL 4; Joint surgery; Trauma

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; PROTEOGLYCAN;

AGED; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; ASPIRATION; BLOOD; BONE TURNOVER; CARTILAGE INJURY; CARTILAGE MATRIX; COMPARATIVE STUDY; CONTROLLED STUDY; EXPERIMENTAL DOG; EXPOSURE; FEMALE; HIP; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PRIORITY JOURNAL; PROFIT; PROTECTION; PROTEOGLYCAN SYNTHESIS; SHOULDER;

ASPIRATION; HAEMARTHROSIS; HAEMOPHILIA; IL-10; IL-4; JOINT SURGERY; TRAUMA;

ANIMALS; CARTILAGE, ARTICULAR; DOGS; HEMARTHROSIS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-4;

EID: 84883019376     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket005     Document Type: Article

References (44)

1. Luck JV Jr, Silva M, Rodriguez-Merchan EC et al. Hemophilic arthropathy. J Am Acad Orthop Surg 200412: 234-45.
2. Myers SL, Brandt KD, O'Connor BL et al. Synovitis and osteoarthritic changes in canine articular cartilage after anterior cruciate ligament transection. Effect of surgical hemostasis. Arthritis Rheum 199033:1406-15.
3. Roosendaal G, Vianen ME, Marx JJ et al. Blood-induced joint damage: a human in vitro study. Arthritis Rheum 199942:1025-32.
4. Hooiveld M, Roosendaal G, Wenting M et al. Short-term exposure of cartilage to blood results in chondrocyte apoptosis. Am J Pathol 2003162:943-51.
5. Hooiveld MJ, Roosendaal G, van den Berg HM et al. Haemoglobin-derived iron-dependent hydroxyl radical formation in blood-induced joint damage: an in vitro study. Rheumatology (Oxford) 200342:784-90.
6. Rodriguez-Merchan EC. Pathogenesis, early diagnosis, and prophylaxis for chronic hemophilic synovitis. Clin Orthop Relat Res 1997;6-11.
7. Roosendaal G, Vianen ME, Wenting MJ et al. Iron deposits and catabolic properties of synovial tissue from patients with haemophilia. J Bone Joint Surg Br 199880:540-5.
8. Hermans C, De Moerloose P, Fischer K et al. Management of acute haemarthrosis in haemophilia A without inhibitors: literature review, European survey and recommendations. Haemophilia 201117:383-92.
9. Wallman P, Carley S. Aspiration of acute traumatic knee haemarthrosis. Emerg Med J 200219:50.
10. Banta JV, Boone DC, Smith CF. Arthrocentesis of the knee in acute hemophilic arthropathy. West J Med 1975122: 285-8.
11. Ingram GI, Mathews JA, Bennett AE. Controlled trial of joint aspiration in acute haemophilic haemarthrosis. Ann Rheum Dis 197231:423.
12. van Roon JA, van Roy JL, Duits A et al. Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T helper-1 activation is inhibited by interleukin-4. Ann Rheum Dis 199554:836-40.
13. Joosten LA, Lubberts E, Durez P et al. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum 199740: 249-60.
14. Joosten LA, Lubberts E, Helsen MM et al. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Arthritis Res 19991:81-91.
15. Kageyama Y, Koide Y, Uchijima M et al. Plasmid encoding interleukin-4 in the amelioration of murine collagen-induced arthritis. Arthritis Rheum 200450: 968-75.
16. Lubberts E, Joosten LA, van Den Bersselaar L et al. Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction. J Immunol 1999163:4546-56.
17. de Waal Malefyt R, Abrams J, Bennett B et al. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991174:1209-20.
18. Lacraz S, Nicod LP, Chicheportiche R et al. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest 199596: 2304-10.
19. Oswald IP, Gazzinelli RT, Sher A et al. IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. J Immunol 1992148: 3578-82.
20. Crepaldi L, Silveri L, Calzetti F et al. Molecular basis of the synergistic production of IL-1 receptor antagonist by human neutrophils stimulated with IL-4 and IL-10. Int Immunol 200214:1145-53.
21. van Roon JA, Lafeber FP, Bijlsma JW. Synergistic activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritis. Arthritis Rheum 200144:3-12.
22. Jansen NW, Roosendaal G, Hooiveld MJ et al. Interleukin-10 protects against blood-induced joint damage. Br J Haematol 2008142:953-61.
23. van Meegeren ME, Roosendaal G, Jansen NW et al. IL-4 alone and in combination with IL-10 protects against blood-induced cartilage damage. Osteoarthritis Cartilage 201220:764-72.
24. Jansen NW, Roosendaal G, Wenting MJ et al. Very rapid clearance after a joint bleed in the canine knee cannot prevent adverse effects on cartilage and synovial tissue. Osteoarthritis Cartilage 200917:433-40.
25. Roosendaal G, Lafeber FP. Pathogenesis of haemophilic arthropathy. Haemophilia 200612(Suppl 3):117-21.
26. Davis ID, Maher DW, Cebon JS et al. A phase I and pharmacokinetic study of subcutaneously-administered recombinant human interleukin-4 (rhuIL-4) in patients with advanced cancer. Growth Factors 200017:287-300.
27. Le Meur Y, Lorgeot V, Aldigier JC et al. Whole blood production of monocytic cytokines (IL-1beta, IL-6, TNF-alpha, sIL-6R, IL-1Ra) in haemodialysed patients. Nephrol Dial Transplant 199914:2420-6.
28. van Roon JA, van Roy JL, Gmelig-Meyling FH et al. Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum 199639:829-35.
29. Radons J, Falk W, Schubert TE. Interleukin-10 does not affect IL-1-induced interleukin-6 and metalloproteinase production in human chondrosarcoma cells, SW1353. Int J Mol Med 200617:377-83.
30. Fabry G. Early changes in the ground substance of articular cartilage in experimental hemarthrosis in dogs, measured by the fixed-charge density method. Arch Orthop Trauma Surg 1989108:76-91.
31. Hooiveld M, Roosendaal G, Vianen M et al. Blood-induced joint damage: longterm effects in vitro and in vivo. J Rheumatol 200330:339-44.
32. Hooiveld MJ, Roosendaal G, Jacobs KM et al. Initiation of degenerative joint damage by experimental bleeding combined with loading of the joint: a possible mechanism of hemophilic arthropathy. Arthritis Rheum 200450: 2024-31.
33. Hooiveld MJ, Roosendaal G, Vianen ME et al. Immature articular cartilage is more susceptible to blood-induced damage than mature articular cartilage: an in vivo animal study. Arthritis Rheum 200348:396-403.
34. Roosendaal G, TeKoppele JM, Vianen ME et al. Blood-induced joint damage: a canine in vivo study. Arthritis Rheum 199942:1033-9.
35. Simon WH, Friedenberg S, Richardson S. Joint congruence. A correlation of joint congruence and thickness of articular cartilage in dogs. J Bone Joint Surg Am 197355: 1614-20.
36. Graichen H, Jakob J, von Eisenhart-Rothe R et al. Validation of cartilage volume and thickness measurements in the human shoulder with quantitative magnetic resonance imaging. Osteoarthritis Cartilage 200311: 475-82.
37. Jansen NW, Roosendaal G, Bijlsma JW et al. Exposure of human cartilage tissue to low concentrations of blood for a short period of time leads to prolonged cartilage damage: an in vitro study. Arthritis Rheum 200756:199-207.
38. Valentino LA, Hakobyan N, Enockson C. Blood-induced joint disease: the confluence of dysregulated oncogenes, inflammatory signals, and angiogenic cues. Semin Hematol 200845:S50-7.
39. Van Meegeren M. Update on pathogenesis of the bleeding joint: an interplay between inflammatory and degenerative pathways. Haemophilia 2010;16(Suppl 5):121-3.
40. Morita Y, Yamamura M, Kawashima M et al. Differential in vitro effects of IL-4, IL-10, and IL-13 on proinflammatory cytokine production and fibroblast proliferation in rheumatoid synovium. Rheumatol Int 200120: 49-54.
41. Finnegan A, Kaplan CD, Cao Y et al. Collagen-induced arthritis is exacerbated in IL-10-deficient mice. Arthritis Res Ther 20035:R18-24.
42. Horsfall AC, Butler DM, Marinova L et al. Suppression of collagen-induced arthritis by continuous administration of IL-4. J Immunol 1997159:5687-96.
43. Roybal JL, Endo M, Radu A et al. Early gestational gene transfer of IL-10 by systemic administration of lentiviral vector can prevent arthritis in a murine model. Gene Ther 201118:719-26.
44. Woods JM, Katschke KJ, Volin MV et al. IL-4 adenoviral gene therapy reduces inflammation, proinflammatory cytokines, vascularization, and bony destruction in rat adjuvant-induced arthritis. J Immunol 2001166: 1214-22.